29/01/2016

We invest in science and innovation

Goodgut capta 615.000€ de financiación

Good Gut, the biotech company located in the Science Park of the University of Girona, has closed its second round of investment for an amount of € 615,000, to advance the clinical validation of a marker for colon cancer and theclinical study of a product targeted to Crohn's disease. Dr. Xavier Aldeguer co-founded GoodGut along with Mariona Serra, doctor of pharmacology, and current CEO of the company, and Jesus Garcia-Gil, professor of microbiology at the University of Girona.